Taken together, the SUMOylation of TOM40 was increased in AD mice cortex and Aβ1‐42 treated SH‐SY5Y cells, indicating that the SUMOylation of TOM40 may associate with AD in the mice model. Here, TOMM40 is linked to Alzheimer disease.